Literature DB >> 9648724

Phosphorylation of p130Cas by angiotensin II is dependent on c-Src, intracellular Ca2+, and protein kinase C.

P P Sayeski1, M S Ali, J B Harp, M B Marrero, K E Bernstein.   

Abstract

p130Cas is a signaling molecule that was initially found to be tyrosine-phosphorylated in v-Crk and v-Src transformed cells. We characterized the regulation of p130Cas tyrosine phosphorylation in vascular smooth muscle cells by angiotensin II (Ang II). This ligand induced a transient increase in p130Cas tyrosine phosphorylation, which was sensitive to the actin polymerization inhibitor cytochalasin D and to the intracellular Ca2+ chelator BAPTA-AM but not the Ca2+ channel blocker verapamil. The Ang II-induced tyrosine phosphorylation of p130Cas was also dependent on an active Src family tyrosine kinase, since it could be blocked by the Src kinase inhibitors geldanamycin and PP1. Ang II treatment resulted in the ability of p130Cas to bind at least 11 different phosphate-containing proteins. Analysis of these proteins revealed that protein kinase Calpha and the cell adhesion signaling molecule pp120 formed temporal associations with p130Cas in response to Ang II. c-Src was found to associate with p130Cas in a manner that was independent of Ang II treatment. Inhibition of protein kinase C by either calphostin C or phorbol 12-myristate 13-acetate downregulation inhibited the Ang II-induced tyrosine phosphorylation of p130Cas. These results are the first to demonstrate that the tyrosine phosphorylation of p130Cas by Ang II is transduced by the Src, intracellular Ca2+, protein kinase C signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648724     DOI: 10.1161/01.res.82.12.1279

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  10 in total

1.  The role of Ca2+ mobilization and heterotrimeric G protein activation in mediating tyrosine phosphorylation signaling patterns in vascular smooth muscle cells.

Authors:  P P Sayeski; M S Ali; K E Bernstein
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 3.  Functional cross-talk between the cyclic AMP and Jak/STAT signaling pathways in vascular smooth muscle cells.

Authors:  S Meloche; S Pelletier; M J Servant
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

4.  Cardiovascular and craniofacial defects in Crk-null mice.

Authors:  Tae-Ju Park; Kelli Boyd; Tom Curran
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

5.  Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice.

Authors:  Annet Kirabo; S Paul Oh; Hideko Kasahara; Kay-Uwe Wagner; Peter P Sayeski
Journal:  J Mol Cell Cardiol       Date:  2011-03-17       Impact factor: 5.000

6.  Enhanced parasympathetic cholinergic activity with galantamine inhibited lipid-induced oxidative stress in obese African Americans.

Authors:  Dena Parsa; Luul A Aden; Ashley Pitzer; Tan Ding; Chang Yu; Andre Diedrich; Ginger L Milne; Annet Kirabo; Cyndya A Shibao
Journal:  Mol Med       Date:  2022-06-03       Impact factor: 6.376

7.  Mutation of glutamic acid residue 1046 abolishes Jak2 tyrosine kinase activity.

Authors:  Dannielle VonDerLinden; Xianyue Ma; Eric M Sandberg; Kim Gernert; Kenneth E Bernstein; Peter P Sayeski
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.842

8.  Dendritic Cell Amiloride-Sensitive Channels Mediate Sodium-Induced Inflammation and Hypertension.

Authors:  Natalia R Barbaro; Jason D Foss; Dmytro O Kryshtal; Nikita Tsyba; Shivani Kumaresan; Liang Xiao; Raymond L Mernaugh; Hana A Itani; Roxana Loperena; Wei Chen; Sergey Dikalov; Jens M Titze; Bjorn C Knollmann; David G Harrison; Annet Kirabo
Journal:  Cell Rep       Date:  2017-10-24       Impact factor: 9.423

9.  Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation.

Authors:  Maura Greiser; Christian R Halaszovich; Dirk Frechen; Peter Boknik; Ursula Ravens; Dobromir Dobrev; Andreas Lückhoff; Ulrich Schotten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-26       Impact factor: 3.195

10.  Jak2 tyrosine kinase residues glutamic acid 1024 and arginine 1113 form a hydrogen bond interaction that is essential for Jak-STAT signal transduction.

Authors:  Eric M Sandberg; Dannielle VonDerLinden; David A Ostrov; Peter P Sayeski
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.842

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.